Qiao Ke
About
Qiao Ke is a scholar working on Hepatology, Surgery and Epidemiology.
According to data from OpenAlex, Qiao Ke has authored 34 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hepatology, 21 papers in Surgery and 10 papers in Epidemiology. Recurrent topics in Qiao Ke's work include Hepatocellular Carcinoma Treatment and Prognosis (17 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (16 papers) and Liver Disease Diagnosis and Treatment (10 papers). Qiao Ke is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (17 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (16 papers) and Liver Disease Diagnosis and Treatment (10 papers). Qiao Ke collaborates with scholars based in China and United States. Qiao Ke's co-authors include Lei Wang, Jingfeng Liu, Yongyi Zeng, Nanping Lin, Fuli Xin, Qizhen Huang, Junxin Wu, Jingrong Li, Wei Guo and Shi Cheng and has published in prestigious journals such as PLoS ONE, Scientific Reports and Frontiers in Immunology.
In The Last Decade
Qiao Ke
31 papers receiving 369 citations
Peers
Qiao Ke
Suzanne Darby United Kingdom
Eleonora Guzzetti Italy
Tzu-Jung Tsai Taiwan
Andrea Fontana Italy
Xishan Li China
C. Verhoef Netherlands
Benjamin Garlipp Germany
Aldrick Ruiz France
Clifton M. Tatum United States
Florian E. Buisman Netherlands
Citations per year, relative to Qiao Ke Qiao Ke (= 1×)
peers
Suzanne Darby
Countries citing papers authored by Qiao Ke
Since
Specialization
Citations
This map shows the geographic impact of Qiao Ke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiao Ke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiao Ke more than expected).
Fields of papers citing papers by Qiao Ke
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Qiao Ke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiao Ke. The network helps show where Qiao Ke may publish in the future.
Co-authorship network of co-authors of Qiao Ke
This figure shows the co-authorship network connecting the top 25 collaborators of Qiao Ke. A scholar is included among the top collaborators of Qiao Ke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiao Ke. Qiao Ke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Wang, Mindy, et al.. (2025). [Clinical study of orelabrutinib combined with R-CHOP regimen for newly diagnosed high-risk non-GCB diffuse large B-cell lymphoma with extranodal involvement].. PubMed. 46(2). 169–173.
2.
Ke, Qiao, et al.. (2024). Immune-targeted therapy with transarterial chemo(embolization) for unresectable HCC: a systematic review and meta-analysis. Frontiers in Immunology. 15. 1421520–1421520.
3.
Ke, Qiao, et al.. (2024). Integrating anoikis and ErbB signaling insights with machine learning and single-cell analysis for predicting prognosis and immune-targeted therapy outcomes in hepatocellular carcinoma. Frontiers in Immunology. 15. 1446961–1446961.
4.
Wu, Wei, Kai Xiong, Qiao Ke, et al.. (2024). External validation of the modified CTP score based on ammonia to predict survival in patients with cirrhosis after TIPS placement. Scientific Reports. 14(1). 13886–13886.
5.
Ke, Qiao, Lei Wang, Ziguo Lin, et al.. (2023). Anatomic versus non-anatomic resection for early-stage intrahepatic cholangiocarcinoma: a propensity score matching and stabilized inverse probability of treatment weighting analysis. BMC Cancer. 23(1). 850–850.
6.
Ke, Qiao, et al.. (2023). Spontaneous portosystemic shunts outside the esophago-gastric region: Prevalence, clinical characteristics, and impact on mortality in cirrhotic patients: A systematic review and meta-analysis. European Journal of Internal Medicine. 112. 77–85.
7.
Ke, Qiao, Jian He, Fuli Xin, et al.. (2023). Resection Margin Width Does Not Influence the Prognosis of Solitary Hepatocellular Carcinoma After Anatomic Resection: A Real-World Study from China. Journal of Hepatocellular Carcinoma. Volume 10. 1353–1365.
8.
Ke, Qiao, Xueping Yu, Xuan Wang, et al.. (2023). Prevalence, clinical characteristics, and outcomes of spontaneous portosystemic shunt in patients with hepatitis B-related cirrhosis: A multicenter study from China. Digestive and Liver Disease. 55(10). 1382–1390.
9.
Wang, Lei, Lu Qiu, Qiao Ke, Hongbing Ji, & Junxin Wu. (2022). Systematic review of adjuvant external beam radiotherapy for hepatocellular carcinoma following radical hepatectomy. Radiotherapy and Oncology. 175. 101–111.
10.
Ke, Qiao, et al.. (2022). The Significance of Transarterial Chemo(Embolization) Combined With Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma in the Era of Systemic Therapy: A Systematic Review. Frontiers in Immunology. 13. 913464–913464.
11.
Ke, Qiao, et al.. (2022). Corrigendum: The Significance of Transarterial Chemo(embolization) Combined With Tyrosine Kinase Inhibitors and Immune Check Point Inhibitors for Unresectable Hepatocellular Carcinoma in the Era of Systemic Therapy: A Systematic Review. Frontiers in Immunology. 13. 952446–952446.
12.
Ke, Qiao, Chunhong Xiao, Qizhen Huang, et al.. (2021). Exploring the clinical value of preoperative serum gamma-glutamyl transferase levels in the management of patients with hepatocellular carcinoma receiving postoperative adjuvant transarterial chemoembolization. BMC Cancer. 21(1). 1117–1117.
13.
Ke, Qiao, Lei Wang, Ziguo Lin, et al.. (2021). Prognostic Value of Lymph Node Dissection for Intrahepatic Cholangiocarcinoma Patients With Clinically Negative Lymph Node Metastasis: A Multi-Center Study From China. Frontiers in Oncology. 11. 585808–585808.
14.
Ke, Qiao, Lei Wang, Weimin Wu, et al.. (2021). Meta-Analysis of Postoperative Adjuvant Hepatic Artery Infusion Chemotherapy Versus Surgical Resection Alone for Hepatocellular Carcinoma. Frontiers in Oncology. 11. 720079–720079.
15.
Lin, Nanping, Jingrong Li, Qiao Ke, Lei Wang, & Jingfeng Liu. (2020). Does intermittent pringle maneuver loss its clinical value in reducing bleeding during hepatectomy? A systematic review and meta-analysis. International Journal of Surgery. 81. 158–164.
16.
Ke, Qiao, et al.. (2020). The effect of adjuvant therapy for patients with intrahepatic cholangiocarcinoma after surgical resection: A systematic review and meta-analysis. PLoS ONE. 15(2). e0229292–e0229292.
17.
Wang, Lei, Qiao Ke, Kongying Lin, et al.. (2020). <p>Not All Hepatocellular Carcinoma Patients with Microvascular Invasion After R0 Resection Could Be Benefited from Prophylactic Transarterial Chemoembolization: A Propensity Score Matching Study</p>. Cancer Management and Research. Volume 12. 3815–3825.
18.
Wang, Lei, Nanping Lin, Fuli Xin, et al.. (2019). A systematic review of the comparison of the incidence of seeding metastasis between endoscopic biliary drainage and percutaneous transhepatic biliary drainage for resectable malignant biliary obstruction. World Journal of Surgical Oncology. 17(1). 116–116.
19.
Ke, Qiao, Bin Wang, Nanping Lin, Lei Wang, & Jingfeng Liu. (2019). Does high-grade dysplasia/carcinoma in situ of the biliary duct margin affect the prognosis of extrahepatic cholangiocarcinoma? A meta-analysis. World Journal of Surgical Oncology. 17(1). 211–211.
20.
Chen, Wensen, Lina Wang, Qiao Ke, et al.. (2008). The role of IGFBP3 functional polymorphisms in the risk of gastric cancer in a high-risk Chinese population. European Journal of Cancer Prevention. 17(2). 82–87.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Suzanne Darby Breakdown of academic impact, for papers by Eleonora Guzzetti Breakdown of academic impact, for papers by Tzu-Jung Tsai Breakdown of academic impact, for papers by Andrea Fontana Breakdown of academic impact, for papers by Xishan Li Breakdown of academic impact, for papers by C. Verhoef Breakdown of academic impact, for papers by Benjamin Garlipp Breakdown of academic impact, for papers by Aldrick Ruiz Breakdown of academic impact, for papers by Clifton M. Tatum Breakdown of academic impact, for papers by Florian E. Buisman